Intra-Cellular Therapies, Inc. Technicals
Intra-Cellular Therapies, Inc. logo

Intra-Cellular Therapies, Inc.(ALLUS_ITCI)

$59.530.25%

Market is closed - opens 7 PM, 02 Jun 2023

Insights

  • Intra-Cellular Therapies, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Intra-Cellular Therapies, Inc. stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Intra-Cellular Therapies, Inc. stock is Range bound.
  • Based on analysis of the Pivot Points, the current market trend for Intra-Cellular Therapies, Inc. stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
53.27
Neutral
Stochastic
13.84, 19.19
Neutral
Ultimate Oscillator
37.99
Neutral
Stochastic Relative Strength Index
0.18, 0.54
Neutral
Moving Average Convergence Divergence
0.36, 1.15
Sell

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
62.27
Sell
20
63.04
Buy
50
58.99
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
61.83
Sell
20
62.02
Buy
50
59.29
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
62.37
Neutral
20
63.14
Sell
50
59.03
Neutral

Double Exponential Moving Average

Period (Days)

Value

Action

10
60.91
Sell
20
62.85
Sell
50
63.84
Buy

Triple Exponential Moving Average

Period (Days)

Value

Action

10
60.05
Sell
20
61.23
Sell
50
65.21
Buy

Pivot

Pivot

Value

Resistance L3
61.64
Resistance L2
61.18
Resistance L1
60.69
Pivot Point
60.23
Support L1
59.74
Support L2
59.28
Support L3
58.79

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.